Document:

Exhibit
10.1

 

COMMON
STOCK PURCHASE AGREEMENT

 

This
COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is dated as of November 18, 2020 by and among Taronis Fuels,
Inc., a Delaware corporation (the “Company”), and each of the Purchasers whose names are set forth on the signature
pages hereto (individually, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS

 

WHEREAS,
the Company and the Purchasers are executing and delivering this Agreement in accordance with and in reliance upon the exemption
from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”),
and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission
(the “Commission”) under the Securities Act; and

 

WHEREAS,
the Company is offering shares of its common stock, par value $0.000001 per share (the “Common Stock”).

 

AGREEMENT

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows:

 

ARTICLE
I

Purchase and Sale of Common Stock

 

Section
1.1 Purchase and Sale of Common Stock. Upon the following terms and conditions, the Company is offering to each Purchaser
the number of shares of Common Stock set forth opposite such Purchaser’s name on such Purchaser’s signature page hereto.
The shares of Common Stock to be issued pursuant to the terms hereof are sometimes referred to herein as the “Shares”.

 

Section
1.2 Purchase Price and Closing. Subject to the terms and conditions hereof, the Company agrees to issue and sell to the
Purchasers and, in consideration of and in express reliance upon the representations, warranties, covenants, terms and conditions
of this Agreement, the Purchasers, severally but not jointly, agree to purchase the Shares for $0.10 per Share for an aggregate
purchase price of up to $10,425,000 (the “Purchase Price”). The closing (the “Closing”)
of the purchase and sale of the shares of Common Stock to be acquired by the Purchasers from the Company under this Agreement
shall take place remotely at such time as the parties hereto have executed this Agreement and all of the conditions set forth
in Article IV hereof and applicable to the Closing shall have been fulfilled or
waived in accordance herewith (the “Closing Date”). Each Purchaser shall deliver to Loeb & Loeb LLP (the
“Escrow Agent”), via wire transfer or a certified check, immediately available funds equal to such Purchaser’s
Purchase Price as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser
its respective Shares.

 

    	 	 	 

    	 

    

 

ARTICLE
II

 

Representations
and Warranties

 

Section
2.1 Representations and Warranties of the Company. Except as set forth in the Schedule of Exceptions attached hereto with
each numbered Schedule corresponding to the section number herein, the Company hereby represents and warrants to the Purchasers
as follows:

 

(a)
Organization, Good Standing and Power. The Company is a corporation duly incorporated, validly existing and in good standing
under the laws of the State of Delaware and has the requisite corporate power to own, lease and operate its properties and assets
and to conduct its business as it is now being conducted. The Company is duly qualified to do business and is in good standing
in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary
except for any jurisdiction(s) (alone or in the aggregate) in which the failure to be so qualified will not have a Material Adverse
Effect (as defined in Section 2.1(g) hereof).

 

(b)
Corporate Power; Authority and Enforcement. The Company has the requisite corporate power and authority to enter into and
perform this Agreement and the Registration Rights Agreement in the form attached hereto as Exhibit A (the “Registration
Rights Agreement” and, together with this Agreement, the “Transaction Documents”), and to issue and
sell the Shares in accordance with the terms hereof. The execution, delivery and performance of the Transaction Documents by the
Company and the consummation by it of the transactions contemplated hereby and thereby have been duly and validly authorized by
all necessary corporate action, and no further consent or authorization of the Company or its Board of Directors (the “Board”)
or stockholders is required. Each of the Transaction Documents constitutes, or shall constitute when executed and delivered, a
valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or
similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable
principles of general application.

 

(c)
Capitalization. The authorized capital stock of the Company and the shares thereof currently issued and outstanding as
of the date hereof is set forth on Schedule 2.1(c) hereto. All of the issued and outstanding shares of the Common Stock
have been duly and validly authorized. Except as contemplated by the Transaction Documents, as set forth on Schedule 2.1(c)
hereto, or as described in the Commission Documents (as defined in Section 2.1(f) below):

 

(i)
no shares of Common Stock are entitled to preemptive, conversion or other rights and there are no outstanding options, warrants,
scrip, rights to subscribe to, call or commitments of any character whatsoever relating to, or securities or rights convertible
into, any shares of capital stock of the Company;

 

(ii)
there are no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional
shares of capital stock of the Company or options, securities or rights convertible into shares of capital stock of the Company;

 

    	2

    	 

    

 

(iii)
the Company is not a party to any agreement granting registration or anti-dilution rights to any person with respect to any of
its equity or debt securities; and

 

(iv)
the Company is not a party to, and it has no knowledge of, any agreement restricting the voting or transfer of any shares of the
capital stock of the Company.

 

The
Company has furnished or made available to the Purchasers true and correct copies of the Company’s Amended and Restated
Certificate of Incorporation, as amended and in effect on the date hereof (the “Certificate of Incorporation”),
and the Company’s Bylaws, as amended and in effect on the date hereof (the “Bylaws”). Except as restricted
under applicable federal, state, local or foreign laws and regulations, the Transaction Documents, or as set forth on Schedule
2.1(c), no written or oral contract, instrument, agreement, commitment, obligation, plan or arrangement of the Company shall
limit the payment of dividends on the Company’s Common Stock.

 

(d)
Issuance of Shares. The Shares to be issued at the Closing have been duly authorized by all necessary corporate action
and the Shares, when paid for or issued in accordance with the terms hereof, will be validly issued and outstanding, fully paid
and nonassessable and, immediately after the Closing, the Purchasers will be the owners of all of such Shares and have good and
valid title to all of such Shares, free and clear of all encumbrances, except as may be imposed under federal and state securities
laws.

 

(e)
Subsidiaries. The Commission Documents (as defined in Section 2.1(f) below) set forth each Subsidiary of the Company, showing
the jurisdiction of its incorporation or organization and showing the percentage of ownership of each Subsidiary. There are no
outstanding preemptive, conversion or other rights, options, warrants or agreements granted or issued by or binding upon any Subsidiary
for the purchase or acquisition of any shares of capital stock of any Subsidiary or any other securities convertible into, exchangeable
for or evidencing the rights to subscribe for any shares of such capital stock. Neither the Company nor any Subsidiary is subject
to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of the capital stock of any
Subsidiary or any convertible securities, rights, warrants or options of the type described in the preceding sentence. Except
as filed as exhibits to the Commission Documents, neither the Company nor any Subsidiary is party to, nor has any knowledge of,
any agreement restricting the voting or transfer of any shares of the capital stock of any Subsidiary. For the purposes of this
Agreement, “Subsidiary” shall mean any corporation or other entity of which at least a majority of the securities
or other ownership interests having ordinary voting power (absolutely or contingently) for the election of directors or other
persons performing similar functions are at the time owned directly or indirectly by the Company and/or any of its other Subsidiaries.

 

    	3

    	 

    

 

(f)
Commission Documents, Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by it with the Commission pursuant to the reporting requirements of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), including material filed pursuant to Section 13(a) or 15(d) of the Exchange
Act (all of the foregoing including filings incorporated by reference therein being referred to herein as the “Commission
Documents”). At the time of the respective filings, the Commission Documents (1) complied in all material respects with
the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder and other federal,
state and local laws, rules and regulations applicable to such documents and (2) did not contain an untrue statement of a material
fact of omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which
they were made, not misleading. The financial statements of the Company included in the Commission Documents (the “Financial
Statements”) complied as of their respective filing dates as to form in all material respects with applicable accounting
requirements and the published rules and regulations of the Commission or other applicable rules and regulations with respect
thereto. The Financial Statements have been prepared in accordance with United States generally accepted accounting principles
(“GAAP”) applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated
in the Financial Statements or the notes thereto or (ii) in the case of unaudited interim statements, to the extent they may not
include footnotes or may be condensed or summary statements), and fairly present in all material respects the consolidated financial
position of the Company as of the dates thereof and the results of operations and cash flows for the periods then ended (subject,
in the case of unaudited statements, to normal year-end audit adjustments).

 

(g)
No Material Adverse Effect. Since December 31, 2019, neither the Company, nor any Subsidiary has experienced or suffered
any Material Adverse Effect. For the purposes of this Agreement, “Material Adverse Effect” means any material
adverse effect on the business, operations, properties, or condition (financial or other) of the Company and its Subsidiaries,
taken as a whole, and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with
the ability of the Company to perform any of its obligations under this Agreement.

 

(h)
No Undisclosed Liabilities. To the knowledge of the Company, other than as may be disclosed in the Commission Documents,
neither the Company nor any Subsidiary has any liabilities, obligations, claims or losses (whether liquidated or unliquidated,
secured or unsecured, absolute, accrued, contingent or otherwise) other than those incurred in the ordinary course of the Company’s
business since December 31, 2019, and those which, individually or in the aggregate, do not have a Material Adverse Effect.

 

(i)
No Undisclosed Events or Circumstances. To the Company’s knowledge, no event or circumstance has occurred or exists
with respect to the Company or any Subsidiary or their respective businesses, properties, operations or condition (financial or
other), which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has
not been so publicly announced or disclosed.

 

    	4

    	 

    

 

(j)
Indebtedness. The Financial Statements set forth all outstanding secured and unsecured Indebtedness of the Company on a
consolidated basis, or for which the Company or any Subsidiary have commitments as of the date of Financial Statements or any
subsequent period that would require disclosure. For the purposes of this Agreement, “Indebtedness” shall mean
(a) any liabilities for borrowed money or amounts owed (other than trade accounts payable incurred in the ordinary course of business),
(b) all guaranties, endorsements and other contingent obligations in respect of Indebtedness of others, whether or not the same
should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement
of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present
value of any lease payments due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary
is in default with respect to any Indebtedness which, individually or in the aggregate, would have a Material Adverse Effect.

 

(k)
Title to Assets. Each of the Company and any Subsidiary has good and marketable title to (i) all properties and assets
purportedly owned or used by them as reflected in the Financial Statements, (ii) all properties and assets necessary for the conduct
of their business as currently conducted, and (iii) all of the real and personal property reflected in the Financial Statements
free and clear of any Lien (as defined in Section 2.1(o) hereof). All leases are valid and subsisting and in full force and effect.

 

(l)
Actions Pending. There is no action, suit, claim, investigation, arbitration, alternate dispute resolution proceeding or
any other proceeding pending or, to the knowledge of the Company, threatened against or involving the Company or any Subsidiary
(i) which questions the validity of this Agreement or any of the other Transaction Documents or the transactions contemplated
hereby or thereby or any action taken or to be taken pursuant hereto or thereto or (ii) involving any of their respective properties
or assets that would be expected to have a Material Adverse Effect. There are no outstanding orders, judgments, injunctions, awards
or decrees of any court, arbitrator or governmental or regulatory body against the Company or any Subsidiary or, to the knowledge
of the Company, any of their respective executive officers or directors in their capacities as such.

 

(m)
Compliance with Law. The Company and each Subsidiary have all franchises, permits, licenses, consents and other governmental
or regulatory authorizations and approvals necessary for the conduct of their respective business as now being conducted by it
unless the failure to possess such franchises, permits, licenses, consents and other governmental or regulatory authorizations
and approvals, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.

 

(n)
No Violation. The business of the Company and each Subsidiary has, to the knowledge of the Company, been conducted in compliance
with all federal, state, local or foreign governmental laws, or rules, regulations and ordinances of any governmental entity.
The Company is not required under federal, state, local or foreign law, rule or regulation to obtain any consent, authorization
or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or
perform any of its obligations under the Transaction Documents, or issue and sell the Shares in accordance with the terms hereof
(other than (x) any consent, authorization or order that has been obtained as of the date hereof, (y) any filing or registration
that has been made as of the date hereof or (z) any filings which may be required to be made by the Company with the Commission
or state securities administrators subsequent to the Closing).

 

    	5

    	 

    

 

(o)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated herein and therein do not and will not (i) violate any provision of the Certificate
of Incorporation or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party
or by which it or its properties or assets are bound, (iii) create or impose a lien, mortgage, security interest, pledge, charge
or encumbrance (collectively, “Lien”) of any nature on any property of the Company under any agreement or any
commitment to which the Company is a party or by which the Company is bound or by which any of its respective properties or assets
are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or
decree (including federal and state securities laws and regulations) applicable to the Company or any of its subsidiaries or by
which any property or asset of the Company or any of its subsidiaries are bound or affected, provided, however,
that, excluded from the foregoing in clauses (ii) and (iii) are such conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect.

 

(p)
Taxes. The Company and each Subsidiary, to the extent its applicable, has accurately prepared and filed all federal, state
and other tax returns required by law to be filed by it, has paid or made provisions for the payment of all taxes shown to be
due and all additional assessments, and adequate provisions have been and are reflected in the consolidated financial statements
of the Company for all current taxes and other charges to which the Company or any Subsidiary, if any, is subject and which are
not currently due and payable. None of the federal income tax returns of the Company have been audited by the Internal Revenue
Service. The Company has no knowledge of any additional assessments, adjustments or contingent tax liability (whether federal,
state or foreign) of any nature whatsoever, whether pending or threatened against the Company or any Subsidiary for any period,
nor of any basis for any such assessment, adjustment or contingency.

 

(q)
Certain Fees. No brokers fees, finder’s fees or financial advisory fees or commissions will be payable by the Company
with respect to the transactions contemplated by this Agreement and the other Transaction Documents, except for a commission payable
to Kingswood Capital Markets, as placement agent for the Company.

 

(r)
Intellectual Property. Each of the Company and its Subsidiaries owns or has the lawful right to use all patents, trademarks,
domain names (whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and
intellectual property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, if any, and
all rights with respect to the foregoing, if any, which are necessary for the conduct of their respective business as now conducted
without any conflict with the rights of others, except where the failure to so own or possess would not have a Material Adverse
Effect.

 

(s)
Books and Records; Internal Accounting Controls. To the Company’s knowledge, the books and records of the Company
and each Subsidiary accurately reflect in all material respects the information relating to the business of the Company and the
Subsidiaries. The Company and each Subsidiary maintains a system of internal accounting controls sufficient, in the judgment of
the Company, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general
or specific authorizations, and (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP.

 

    	6

    	 

    

 

(t)
Material Agreements. Any and all written or oral contracts, instruments, agreements, commitments, obligations, plans or
arrangements, the Company and each Subsidiary is a party to, that a copy of which would be required to be filed with the Commission
as an exhibit to a registration statement on Form S-1 (collectively, the “Material Agreements”) if the Company
or any Subsidiary were registering securities under the Securities Act, have previously been publicly filed with the Commission
in the Commission Documents. Each of the Company and the Subsidiaries has in all material respects performed all the obligations
required to be performed by them to date under the foregoing agreements, have received no notice of default and are not in default
under any Material Agreement now in effect.

 

(u)
Transactions with Affiliates. Except as set forth in the Financial Statements or in the Commission Documents, there are
no loans, leases, agreements, contracts, royalty agreements, management contracts or arrangements or other continuing transactions
between (a) the Company or any Subsidiary on the one hand, and (b) on the other hand, any officer, employee, consultant or director
of the Company, or any of its Subsidiaries, or any person owning any capital stock of the Company or any Subsidiary or any member
of the immediate family of such officer, employee, consultant, director or stockholder or any corporation or other entity controlled
by such officer, employee, consultant, director or stockholder, or a member of the immediate family of such officer, employee,
consultant, director or stockholder.

 

(v)
Securities Act of 1933. Assuming the accuracy of the representations of the Purchasers set forth in Section 2.2 hereof,
the Company has complied with all applicable federal and state securities laws in connection with the offer, issuance and sale
of the Shares hereunder. Neither the Company nor anyone acting on its behalf, directly or indirectly, has or will sell, offer
to sell or solicit offers to buy any of the shares of Common Stock or similar securities to, or solicit offers with respect thereto
from, or enter into any preliminary conversations or negotiations relating thereto with, any person, or has taken or will take
any action so as to bring the issuance and sale of any of the shares of Common Stock in violation of the registration provisions
of the Securities Act and applicable state securities laws, and neither the Company nor any of its affiliates, nor any person
acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D under the Securities Act) in connection with the offer or sale of any of the shares of Common Stock.

 

(w)
Governmental Approvals. Except for the filing of any notice prior or subsequent to the Closing Date that may be required
under applicable state and/or federal securities laws (which if required, shall be filed on a timely basis), including the filing
of a Form D and a registration statement or statements pursuant to the Registration Rights Agreement, no authorization, consent,
approval, license, exemption of, filing or registration with any court or governmental department, commission, board, bureau,
agency or instrumentality, domestic or foreign, is or will be necessary for, or in connection with, the execution or delivery
of the Shares, or for the performance by the Company of its obligations under the Transaction Documents.

 

    	7

    	 

    

 

(x)
Employees. Neither the Company nor any Subsidiary has any collective bargaining arrangements covering any of its employees.
Since December 31, 2019, no executive officer of the Company has terminated or, to the knowledge of the Company, has any present
intention of terminating his or her employment with the Company or any Subsidiary, except as set forth in the Commission Documents.

 

(y)
Investment Company Act. The Company is not, and is not an affiliate of, and immediately after receipt of payment for the
Shares, will not be or be an affiliate of, an “investment company” within the meaning of the Investment Company Act
of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company”
subject to registration under the Investment Company Act of 1940, as amended.

 

(z)
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has
directly or indirectly made any offers or sales of any security or solicited any offers to buy any security under circumstances
that would cause the offering of the Shares pursuant to this Agreement to be integrated with prior offerings by the Company for
purposes of the Securities Act which would prevent the Company from selling the Shares pursuant to Rule 506 under the Securities
Act, nor will the Company or any of its affiliates take any action or steps that would cause the offering of the Shares to be
integrated with other offerings.

 

(aa)
Sarbanes-Oxley Act. The Company is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley
Act of 2002 (the “Sarbanes-Oxley Act”), and the rules and regulations promulgated thereunder, that are effective
and for which compliance by the Company is required as of the date hereof.

 

(bb)
No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule
405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered
Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule
506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a
Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Purchasers a copy of any disclosures provided thereunder.

 

(cc)
Other Covered Persons. Other than Kingswood Capital Markets, as placement agent for the Company, the Company is not aware
of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation
of purchasers in connection with the sale of any Common Stock.

 

    	8

    	 

    

 

(dd)
Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i)
any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably
be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

 

Section
2.2 Representations and Warranties of the Purchasers. Each Purchaser hereby makes the following representations and warranties
to the Company as of the date hereof, with respect solely to itself and not with respect to any other Purchaser:

 

(a)
Organization and Good Standing of the Purchasers. If the Purchaser is an entity, such Purchaser is a corporation, partnership
or limited liability company duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction
of its incorporation or organization.

 

(b)
Authorization and Power. Such Purchaser has the requisite power and authority to enter into and perform this Agreement
and each of the other Transaction Documents to which such Purchaser is a party and to purchase the shares of Common Stock being
sold to it hereunder. The execution, delivery and performance of this Agreement and each of the other Transaction Documents to
which such Purchaser is a party by such Purchaser and the consummation by it of the transactions contemplated hereby and thereby
have been duly authorized by all necessary corporate, partnership or limited liability company action, and no further consent
or authorization of such Purchaser or its Board of Directors, stockholders, partners, members, or managers, as the case may be,
is required. This Agreement and each of the other Transaction Documents to which such Purchaser is a party has been duly authorized,
executed and delivered by such Purchaser and constitutes, or shall constitute when executed and delivered, a valid and binding
obligation of such Purchaser enforceable against such Purchaser in accordance with the terms hereof, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or
similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable
principles of general application.

 

(c)
No Conflicts. The execution, delivery and performance of this Agreement and each of the other Transaction Documents to
which such Purchaser is a party and the consummation by such Purchaser of the transactions contemplated hereby and thereby or
relating hereto do not and will not (i) result in a violation of such Purchaser’s charter documents, bylaws, operating agreement,
partnership agreement or other organizational documents or (ii) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of any agreement, indenture or instrument or obligation to which such Purchaser is a party or by which its properties
or assets are bound, or result in a violation of any law, rule, or regulation, or any order, judgment or decree of any court or
governmental agency applicable to such Purchaser or its properties (except for such conflicts, defaults and violations as would
not, individually or in the aggregate, have a material adverse effect on such Purchaser). Such Purchaser is not required to obtain
any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for
it to execute, deliver or perform any of its obligations under this Agreement or any other Transaction Document to which such
Purchaser is a party or to purchase the shares of Common Stock in accordance with the terms hereof, provided, that for purposes
of the representation made in this sentence, such Purchaser is assuming and relying upon the accuracy of the relevant representations
and agreements of the Company herein.

 

    	9

    	 

    

 

(d)
Status of Purchasers. Such Purchaser is an “accredited investor” as defined in Regulation D under the Securities
Act. Such Purchaser is not required to be registered as a broker-dealer under Section 15 of the Exchange Act and such Purchaser
is not a broker-dealer, nor an affiliate of a broker-dealer.

 

(e)
Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of its prospective investment
in the Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Shares and, at the present time, is able to afford a complete loss of such investment. Such Purchaser
understands that no United States federal or state agency or any other governmental or state agency has passed on or made recommendations
or endorsement of the shares of Common Stock to be acquired by such Purchaser hereunder or the suitability of the investment therein,
nor have such authorities passed upon or endorsed the merits of the transactions set forth herein.

 

(f)
Acquisition for Investment. Such Purchaser is acquiring the shares of Common Stock solely for its own account for the purpose
of investment and not with a view to or for sale in connection with a distribution. Such Purchaser does not have a present intention
to sell the shares of Common Stock, nor a present arrangement (whether or not legally binding) or intention to effect any distribution
of the shares of Common Stock to or through any person or entity; provided, however, that by making the representations
herein, such Purchaser does not agree to hold the shares of Common Stock for any minimum or other specific term and reserves the
right to dispose of the shares of Common Stock at any time in accordance with federal and state securities laws applicable to
such disposition. Such Purchaser acknowledges that it is able to bear the financial risks associated with an investment in the
shares of Common Stock and that it has been given full access to such records of the Company and to the officers of the Company
and received such information as it has deemed necessary or appropriate to conduct its due diligence investigation and has sufficient
knowledge and experience in investing in companies similar to the Company in terms of the Company’s stage of development
so as to be able to evaluate the risks and merits of its investment in the Company.

 

(g)
Opportunities for Additional Information. Such Purchaser acknowledges that such Purchaser has had the opportunity to ask
questions of and receive answers from, or obtain additional information from, the executive officers of the Company concerning
the financial and other affairs of the Company.

 

(h)
No General Solicitation. Such Purchaser acknowledges that the Shares were not offered to such Purchaser by means of any
form of general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including
(i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast
over television or radio, or (ii) any seminar or meeting to which such Purchaser was invited by any of the foregoing means of
communications.

 

    	10

    	 

    

 

(i)
Rule 144. Such Purchaser understands that the Shares must be held indefinitely unless such Shares are registered under
the Securities Act or an exemption from registration is available. Such Purchaser acknowledges that such Purchaser is familiar
with Rule 144, of the rules and regulations of the Commission, as amended, promulgated pursuant to the Securities Act (“Rule
144”), and that such Purchaser has been advised that Rule 144 permits resales only under certain circumstances. Such
Purchaser understands that to the extent that Rule 144 is not available, such Purchaser will be unable to sell any Shares without
either registration under the Securities Act or the existence of another exemption from such registration requirement.

 

(j)
Reliance. Such Purchaser understands that the Shares are being offered and sold in reliance on a transactional exemption
from the registration requirements of federal and state securities laws and the Company is relying upon the truth and accuracy
of the representations, warranties, agreements, acknowledgments and understandings of such Purchaser set forth herein in order
to determine the applicability of such exemptions and the suitability of such Purchaser to acquire the Shares.

 

(k)
Independent Investment. Such Purchaser has not agreed to act with any other Purchaser for the purpose of acquiring, holding,
voting or disposing of the Shares purchased hereunder for purposes of Section 13(d) under the Exchange Act, and such Purchaser
is acting independently with respect to its investment in the Shares.

 

(l)
Brokers. Except for a commission payable to Kingswood Capital Markets, as placement agent for the Company, such Purchaser
has no knowledge of any brokerage or finder’s fees or commissions that are or will be payable by the Company to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other person or entity with respect to the
transactions contemplated by this Agreement.

 

(m)
Confidential Information. Such Purchaser agrees that such Purchaser and its affiliates, employees, agents and representatives
will keep confidential and will not disclose, divulge or use (other than for purposes of monitoring its investment in the Company)
any confidential information which such Purchaser may obtain from the Company pursuant to financial statements, reports and other
materials submitted by the Company to such Purchaser pursuant to this Agreement, unless such information is known to the public
through no fault of such Purchaser or his, her or its employees or representatives; provided, however, that such Purchaser may
disclose such information (i) to its attorneys, accountants and other professionals in connection with their representation of
such Purchaser in connection with such Purchaser’s investment in the Company, (ii) to any prospective permitted transferee
of the Shares, so long as the prospective transferee agrees to be bound by the provisions of this Section 2.2(l), or (iii) to
any general partner or affiliate of such Purchaser; or (iii) as required by applicable law.

 

    	11

    	 

    

  

ARTICLE
III

 

Covenants

 

The
Company covenants with each of the Purchasers as follows, which covenants are for the benefit of the Purchasers and their permitted
assignees (as defined herein).

 

Section
3.1 Securities Compliance. The Company shall notify the Commission in accordance with its rules and regulations, of the
transactions contemplated by any of the Transaction Documents, including filing a Form D with respect to the Shares as required
under Regulation D and applicable “blue sky” laws, and shall take all other necessary action and proceedings as may
be required by applicable law, rule and regulation, for the legal and valid issuance of the Shares to the Purchasers or subsequent
holders.

 

Section
3.2 Compliance with Laws. The Company shall take all reasonable efforts to comply with, and cause each Subsidiary to take
all reasonable efforts to comply with, in all material respects, all applicable laws, rules, regulations and orders.

 

Section
3.3 Reporting Status. So long as a Purchaser beneficially owns any of the Shares and the Company is subject to the reporting
requirements under the Exchange Act, the Company shall timely file, by the date due or any such extension thereof, all reports
required to be filed with the Commission pursuant to the Exchange Act, and the Company shall not cease to file reports under the
Exchange Act while it is subject to the reporting requirements under the Exchange Act.

 

Section
3.4 Disclosure of Transaction. The Company shall (a) promptly following the date hereof, issue a press release disclosing
the material terms of the transactions contemplated hereby (the “Press Release”), and (b) file a Current Report
on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within four (4) Business Day following
the Closing Date. “Business Day” means any day during which the principal exchange in which the Common Stock
is trading shall be open for trading.

 

Section
3.5 Disclosure of Material Information. The Company and the Subsidiaries covenant and agree that neither it nor any other
person acting on its or their behalf has provided or, from and after the filing of the Press Release, will provide any Purchaser
or its agents or counsel with any information that the Company believes constitutes material non-public information (other than
with respect to the transactions contemplated by this Agreement), unless prior thereto such Purchaser shall have executed a specific
written agreement regarding the confidentiality and use of such information. The Company understands and confirms that each Purchaser
shall be relying on the foregoing covenants in effecting transactions in securities of the Company. At the time of the filing
of the Press Release, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any
of its subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the Press Release.
The Company shall not disclose the identity of any Purchaser in any filing with the Commission except as required by the rules
and regulations of the Commission thereunder.

 

Section
3.6 No Integrated Offerings. The Company shall not make any offers or sales of any security (other than the securities
being offered or sold hereunder) under circumstances that would require registration of the securities being offered or sold hereunder
under the Securities Act.

 

    	12

    	 

    

 

Section
3.7 Use of Proceeds. The Company shall use the net proceeds from the sale of the Shares to repay indebtedness for borrowed
money in an amount up to $5,000,000 and any balance shall be used for general corporate and working capital purposes.

 

Section
3.8 Additional Covenants of the Company. The Company shall: (a) request the Company’s Board put to vote a proposal
to remove the existing “staggered board” structure at the Company’s next Board meeting; (b) not implement any
super-voting or similar rights with respect to the Common Stock, and (c) refrain from filing any Certificate of Designations with
the Delaware Secretary of State to create any class of preferred equity without the Purchasers’ prior written approval until
the earlier of the following: (i) the Company up lists to a national exchange, or (ii) the Purchasers, in the aggregate, no longer
own at least fifty percent (50.00%) of the Shares purchased pursuant to this Agreement.

 

ARTICLE
IV

 

CONDITIONS

 

Section
4.1 Conditions Precedent to the Obligation of the Company to Sell the Shares. The obligation hereunder of the Company to
issue and sell the Shares to the Purchasers is subject to the satisfaction or waiver, at or before each Closing, of each of the
conditions set forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any
time in its sole discretion.

 

(a)
Accuracy of Each Purchaser’s Representations and Warranties. Each of the representations and warranties of each Purchaser
in this Agreement and the other Transaction Documents that are qualified by materiality or by reference to any Material Adverse
Effect shall be true and correct in all respects, and all other representations and warranties shall be true and correct in all
material respects, as of the date when made and as of the Closing Date as though made at that time, except for representations
and warranties that are expressly made as of a particular date, which shall be true and correct in all respects as of such date.

 

(b)
Performance by the Purchasers. Each Purchaser shall have performed, satisfied and complied in all respects with all covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior
to the Closing.

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d)
Delivery of Purchase Price. The Purchase Price for each of the Shares shall have been delivered to the Escrow Agent.

 

    	13

    	 

    

 

(e)
Delivery of Transaction Documents. The Transaction Documents to which the Purchasers are parties shall have been duly executed
and delivered by the Purchasers to the Company.

 

Section
4.2 Conditions Precedent to the Obligation of the Purchasers to Purchase the Shares. The obligation hereunder of each Purchaser
to acquire and pay for the Shares is subject to the satisfaction or waiver, at or before each Closing, of each of the conditions
set forth below. These conditions are for each Purchaser’s sole benefit and may be waived by such Purchaser at any time
in its sole discretion.

 

(a)
Accuracy of the Company’s Representations and Warranties. Each of the representations and warranties of the Company
in this Agreement and the other Transaction Documents that are qualified by materiality or by reference to any Material Adverse
Effect shall be true and correct in all respects, and all other representations and warranties shall be true and correct in all
material respects, as of the date when made and as of the Closing Date as though made at that time, except for representations
and warranties that are expressly made as of a particular date, which shall be true and correct in all respects as of such date.

 

(b)
Performance by the Company. The Company shall have performed, satisfied and complied in all respects with all covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to
the Closing.

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any
of the transactions contemplated by this Agreement.

 

(d)
No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any governmental authority shall have
been commenced, and no investigation by any governmental authority shall have been threatened, against the Company or any Subsidiary,
or any of the officers, directors or affiliates of the Company or any Subsidiary seeking to restrain, prevent or change the transactions
contemplated by this Agreement, or seeking damages in connection with such transactions.

 

(e)
Opinion of Counsel. At the Closing, the Purchasers shall have received an opinion of securities counsel to the Company,
dated the date of the Closing, in a form reasonably acceptable to the Purchasers.

 

(f)
Delivery of Transaction Documents. The Transaction Documents to which the Purchasers are parties shall have been duly executed
and delivered by the Company to the Purchasers..

 

(g)
Delivery of Shares. Promptly following each Closing, the Company shall cause its transfer agent to (i) credit the Shares
being acquired the Purchasers at Closing in book-entry form to each Purchaser’s balance account with the Depository Trust
Company through its Deposit Withdrawal Agent Commission system, or (ii) at the request of a Purchaser, deliver to such Purchaser
the certificate for the Shares being acquired by such Purchaser at the Closing to such address set forth next to such Purchaser’s
name on the signature pages hereto.

 

    	14

    	 

    

 

(h)
Secretary’s Certificate. The Secretary of the Company shall have delivered to the Purchasers at the Closing a certificate
certifying as to the accuracy of (i) the Certificate of Incorporation, (ii) the Bylaws, and (iii) resolutions of the Board approving
the Transaction Agreements and the transactions contemplated thereunder.

 

(i)
Officer’s Certificate. The Company shall have delivered to the Purchasers a certificate of an executive officer of
the Company, dated as of the Closing Date, confirming the accuracy of the Company’s representations, warranties and covenants
as of the Closing Date and confirming the compliance by the Company with the conditions precedent set forth in this Section 4.2
as of the Closing Date.

 

ARTICLE
V

Stock Certificate Legend

 

Section
5.1 Legend. Each certificate or “book entry” statement representing the Shares shall be stamped or otherwise
imprinted with a legend substantially in the following form (in addition to any legend required by applicable state securities
or “blue sky” laws):

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE
DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR THE COMPANY SHALL HAVE RECEIVED
AN OPINION OF COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE
SECURITIES LAWS IS NOT REQUIRED.”

 

    	15

    	 

    

 

The
Company agrees to cause its transfer agent to reissue certificates representing any of the shares of Common Stock without the
legend set forth above so long as such legend removal is in connection with a sale transaction and such holder thereof shall give
written notice to the Company describing the manner and terms of such sale and removal as the Company may reasonably request.
In addition, such proposed transfer and removal will not be effected until: (a) either (i) the Company has received an opinion
of counsel reasonably satisfactory to the Company, to the effect that the registration of the shares of Common Stock under the
Securities Act is not required in connection with such proposed transfer, (ii) a registration statement under the Securities Act
covering such proposed disposition has been filed by the Company with the Commission and has become effective under the Securities
Act, or (iii) the Company has received other evidence reasonably satisfactory to the Company that such registration and qualification
under the Securities Act and state securities laws are not required; and (b) either (i) the Company has received an opinion of
counsel reasonably satisfactory to the Company, to the effect that registration or qualification under the securities or “blue
sky” laws of any state is not required in connection with such proposed disposition, or (ii) compliance with applicable
state securities or “blue sky” laws has been effected or a valid exemption exists with respect thereto. The Company
will respond to any such notice from a holder within five (5) Business Days. In the case of any proposed transfer under this Section
5.1, the Company will use reasonable efforts to comply with any such applicable state securities or “blue sky” laws,
but shall in no event be required, (x) to qualify to do business in any state where it is not then qualified, (y) to take any
action that would subject it to tax or to the general service of process in any state where it is not then subject, or (z) to
comply with state securities or “blue sky” laws of any state for which registration by coordination is unavailable
to the Company. The restrictions on transfer contained in this Section 5.1 shall be in addition to, and not by way of limitation
of, any other restrictions on transfer contained in any other section of this Agreement. Whenever a certificate representing the
shares of Common Stock is permitted to be issued to a Purchaser without a legend, in lieu of delivering physical certificates
representing the shares of Common Stock (provided that a registration statement under the Securities Act providing for the resale
of the shares of Common Stock is then in effect and such shares have been sold), the Company may cause its transfer agent to electronically
transmit the shares of Common Stock to a Purchaser by crediting the account of such Purchaser or such Purchaser’s prime
broker with the DTC through its DWAC system (to the extent not inconsistent with any provisions of this Agreement). In addition,
the Company will provide, at the Company’s expense, such legal opinions in the future as are reasonably necessary for the
issuance and public resale of the Common Stock pursuant to an effective registration statement, Rule 144 under the Securities
Act or an exemption from registration under the Securities Act and applicable “blue sky” laws, which opinion, if issued,
shall be deemed to satisfy the requirements of third paragraph of this Section 5.1. Without limiting the generality of the foregoing,
in the event that shares of Common Stock are sold in a manner that complies with an exemption from registration (including pursuant
to Rule 144), the Company shall promptly instruct its counsel (at its expense) to issue to the transfer agent an opinion permitting
removal of any legend restricting transfer pursuant to Section 5.1 hereof.

 

ARTICLE
VI

Indemnification

 

Section
6.1 General Indemnity. The Company agrees to indemnify and hold harmless the Purchasers (and their respective directors,
officers, managers, partners, members, shareholders, affiliates, agents, successors and assigns) from and against any and all
losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees,
charges and disbursements) incurred by the Purchasers as a result of any breach of the representations, warranties or covenants
made by the Company herein. Each Purchaser severally but not jointly agrees to indemnify and hold harmless the Company and its
directors, officers, affiliates, agents, successors and assigns from and against any and all losses, liabilities, deficiencies,
costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred
by the Company as a result of any breach of the representations, warranties or covenants made by such Purchaser herein. The maximum
aggregate liability of each Purchaser pursuant to its indemnification obligations under this Article VI shall not exceed the portion
of the Purchase Price paid by such Purchaser hereunder. In no event shall any “Indemnified Party” (as defined below)
be entitled to recover consequential or punitive damages resulting from a breach or violation of this Agreement.

 

    	16

    	 

    

 

Section
6.2 Indemnification Procedure. Any party entitled to indemnification under this Article VI (an “Indemnified Party”)
will give written notice to the indemnifying party of any matters giving rise to a claim for indemnification; provided,
that the failure of any party entitled to indemnification hereunder to give notice as provided herein shall not relieve the indemnifying
party of its obligations under this Article VI except to the extent that the indemnifying party is materially prejudiced by such
failure to give notice. In case any action, proceeding or claim is brought against an Indemnified Party in respect of which indemnification
is sought hereunder, the indemnifying party shall be entitled to participate in and, unless in the reasonable judgment of the
Indemnified Party a conflict of interest between it and the indemnifying party may exist with respect of such action, proceeding
or claim, to assume the defense thereof with counsel reasonably satisfactory to the Indemnified Party. In the event that the indemnifying
party advises an Indemnified Party that it will contest such a claim for indemnification hereunder, or fails, within thirty (30)
days of receipt of any indemnification notice to notify, in writing, such person of its election to defend, settle or compromise,
at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at any time after it commences such
defense), then the Indemnified Party may, at its option, defend, settle or otherwise compromise or pay such action or claim. In
any event, unless and until the indemnifying party elects in writing to assume and does so assume the defense of any such claim,
proceeding or action, the Indemnified Party’s costs and expenses arising out of the defense, settlement or compromise of
any such action, claim or proceeding shall be losses subject to indemnification hereunder. The Indemnified Party shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying
party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party, which relates
to such action or claim. The indemnifying party shall keep the Indemnified Party fully apprised at all times as to the status
of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects to defend any such action
or claim, then the Indemnified Party shall be entitled to participate in such defense with counsel of its choice at its sole cost
and expense. The indemnifying party shall not be liable for any settlement of any action, claim or proceeding effected without
its prior written consent (which consent will not be unreasonably withheld or delayed), provided, however, that
the indemnifying party shall be liable for any settlement if the indemnifying party is advised of the settlement but fails to
respond to the settlement within thirty (30) days of receipt of such notification. Notwithstanding anything in this Article VI
to the contrary, the indemnifying party shall not, without the Indemnified Party’s prior written consent, settle or compromise
any claim or consent to entry of any judgment in respect thereof which imposes any future obligation on the Indemnified Party
or which does not include, as an unconditional term thereof, the giving by the claimant or the plaintiff to the Indemnified Party
of a release from all liability in respect of such claim. The indemnity agreements contained herein shall be in addition to (a)
any cause of action or similar rights of the Indemnified Party against the indemnifying party or others, and (b) any liabilities
the indemnifying party may be subject to pursuant to the law.

 

ARTICLE
VII

Miscellaneous

 

Section
7.1 Fees and Expenses. Except as otherwise set forth in this Agreement and the other Transaction Documents, each party
shall pay the fees and expenses of its advisors, counsel, accountants and other experts, if any, and all other expenses, incurred
by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement and the other Transaction
Documents.

 

    	17

    	 

    

 

Section
7.2 Specific Enforcement; Consent to Jurisdiction.

 

(a)
The Company and the Purchasers acknowledge and agree that irreparable damage may occur in the event that any of the provisions
of this Agreement or the other Transaction Documents were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties may be entitled to an injunction or injunctions to prevent or cure breaches
of the provisions of this Agreement or the other Transaction Documents and to enforce specifically the terms and provisions hereof
or thereof, this being in addition to any other remedy to which any of them may be entitled by law or equity.

 

(b)
Each of the Company and the Purchasers (i) hereby irrevocably submits to the jurisdiction of the United States District Court
sitting in the Southern District of New York and the courts of the State of New York located in New York county for the purposes
of any suit, action or proceeding arising out of or relating to this Agreement or any of the other Transaction Documents or the
transactions contemplated hereby or thereby and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought
in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Company and the Purchasers
consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section
7.2 shall affect or limit any right to serve process in any other manner permitted by law. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law.

 

Section
7.3 Entire Agreement; Amendment. This Agreement and the other Transaction Documents contains the entire understanding and
agreement of the parties with respect to the matters covered hereby and, except as specifically set forth herein or in the Transaction
Documents, neither the Company nor any of the Purchasers makes any representations, warranty, covenant or undertaking with respect
to such matters and they supersede all prior understandings and agreements with respect to said subject matter, all of which are
merged herein. No provision of this Agreement nor any of the Transaction Documents may be waived or amended other than by a written
instrument signed by the Company and the holders of over fifty percent (50%) of the Shares then outstanding, and no provision
hereof may be waived other than by a written instrument signed by the party against whom enforcement of any such waiver is sought.
No such amendment shall be effective to the extent that it applies to less than all of the holders of the Shares then outstanding.
No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of any
of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.

 

    	18

    	 

    

 

Section
7.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication
is delivered via electronic mail (“Email”) at the Email address set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via Email at the Email address set forth on the signature pages attached hereto on a day
that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth
on the signature pages attached hereto.

 

Section
7.5 Waivers. No waiver by any party of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any other provisions, condition or requirement hereof,
nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right
accruing to it thereafter.

 

Section
7.6 Headings. The section headings contained in this Agreement (including, without limitation, section headings and headings
in the exhibits and schedules) are inserted for reference purposes only and shall not affect in any way the meaning, construction
or interpretation of this Agreement. Any reference to the masculine, feminine, or neuter gender shall be a reference to such other
gender as is appropriate. References to the singular shall include the plural and vice versa.

 

Section
7.7 Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the
Company or the Purchasers, as applicable, provided, however, that, subject to federal and state securities laws
and as otherwise provided in the Transaction Documents, a Purchaser may assign its rights and delegate its duties hereunder in
whole or in part (i) to a third party acquiring all or substantially all of its shares of Common Stock in a private transaction
or (ii) to an affiliate, in each case, without the prior written consent of the Company or the other Purchasers, after notice
duly given by such Purchaser to the Company provided, that no such assignment or obligation shall affect the obligations
of such Purchaser hereunder and that such assignee agrees in writing to be bound, with respect to the transferred securities,
by the provisions hereof that apply to the Purchasers. The provisions of this Agreement shall inure to the benefit of and be binding
upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended
to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

Section
7.8 No Third Party Beneficiaries. Except as set forth in Article VI, this Agreement is intended for the benefit of the
parties hereto and their respective permitted successors and assigns and is not for the benefit of, nor may any provision hereof
be enforced by, any other person.

 

    	19

    	 

    

 

Section
7.9 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of New York, without giving effect to any of the conflicts of law principles which would result in the application of the substantive
law of another jurisdiction. This Agreement shall not be interpreted or construed with any presumption against the party causing
this Agreement to be drafted.

 

Section
7.10 Survival. The representations and warranties of the Company and the Purchasers shall survive the execution and delivery
hereof and the Closing hereunder for a period of one (1) year following the Closing Date.

 

Section
7.11 Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be
deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective
when counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall
create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same
force and effect as if such facsimile signature were the original thereof.

 

Section
7.12 Publicity. The Company agrees that it will not disclose, and will not include in any public announcement, the name
of the Purchasers without the consent of the Purchasers unless and until such disclosure is required by law or applicable regulation,
and then only to the extent of such requirement.

 

Section
7.13 Severability. The provisions of this Agreement and the Transaction Documents are severable and, in the event that
any court of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained
in this Agreement or the Transaction Documents shall, for any reason, be held to be invalid, illegal or unenforceable in any respect,
such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement
or the Transaction Documents and such provision shall be reformed and construed as if such invalid or illegal or unenforceable
provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable
to the maximum extent possible.

 

Section
7.14 Further Assurances. From and after the date of this Agreement, upon the request of any Purchaser or the Company, each
of the Company and the Purchasers shall execute and deliver such instrument, documents and other writings as may be reasonably
necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of the Transaction Documents.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	20

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Common Stock Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	TARONIS
    FUELS, INC. 	 	Address
    for Notice:
	 	 	 
	By:	                                          	 	Taronis
    Fuels, Inc.
	Name:	Scott
    Mahoney	 	24980
    N. 83rd Avenue, Ste. 100
	Title:	Chief
    Executive Officer	 	Peoria,
    Arizona 85383
	 	 	 	Attention:
    Tyler B. Wilson, Esq.
	 	 	 	Telephone
    No.: (866) 370-3835
	 	 	 	Email:
    tylerwilson@taronisfuels.com
	With
    a copy to (which shall not constitute notice):	 	 
	 	 	 
	Anthony
    L.G., PLLC	 	 
	625
    N. Flagler Drive, Suite 600 West Palm Beach, FL	 	 
	33401
    Attn: Laura Anthony, Esq.	 	 
	Email:
    LAnthony@AnthonyPLLC.com	 	 

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE
PAGE FOR PURCHASERS FOLLOWS]

 

    	21

    	 

    

 

[PURCHASER
SIGNATURE PAGE TO COMMON STOCK PURCHASE AGREEMENT]

 

IN
WITNESS WHEREOF, the undersigned have caused this Common Stock Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

Name
of Purchaser: ________________________________________________________

 

Signature
of Authorized Signatory of Purchaser: __________________________________

 

Name
of Authorized Signatory: ____________________________________________________

 

Title
of Authorized Signatory: _____________________________________________________

 

Email
Address of Authorized Signatory: ______________________________________________

 

Facsimile
Number of Authorized Signatory: _____________________________________________

 

Address
for Notice to Purchaser:

 

Address
for Delivery of Shares to Purchaser (if not same as address for notice):

 

Subscription
Amount: $_________________

 

Shares
of Common Stock: _________________

 

Purchaser’s
Tax I.D. or Social Security Number: _______________________

 

    	22

    	 

    

 

EXHIBIT
A TO THE

COMMON STOCK PURCHASE AGREEMENT

 

 

 
 

FORM
OF REGISTRATION RIGHTS AGREEMENT

 

    	 	B-1	 

    	 

    

 

Schedule
2.1(c)

Capitalization

 

Authorized
Capital Stock

 

The
Company’s Amended and Restated Certificate of Incorporation authorizes 950,000,000 shares of common stock, $0.000001 par
value per share (“Common Stock”), and 50,000,000 shares of preferred stock, $0.000001 par value per share (“Preferred
Stock”).

 

Issued
and Outstanding Capital Stock

 

As
of November 18, 2020, there were 340,362,615 shares of our Common Stock outstanding, and no shares of Preferred Stock outstanding.Exhibit
10.2

 

REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights Agreement (this “Agreement”) is made and entered into as of November 18, 2020, by and among
Taronis Fuels, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser”
and collectively, the “Purchasers”). This Agreement is made pursuant to the Common Stock Purchase Agreement,
dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).

 

The
Company and each Purchaser hereby agrees as follows:

 

1.
Definitions.

 

Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms
in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have the meaning set forth in Section 6(d).

 

“Effectiveness
Date” means, with respect to the Initial Registration Statement required to be filed hereunder, the 90th
calendar day following the Closing Date (or, in the event of a “full review” by the Commission, the 120th
calendar day following the Closing Date) and with respect to any additional Registration Statements which may be required pursuant
to Section 2(c), the 60th calendar day following the date on which an additional Registration Statement is required
to be filed hereunder (or, in the event of a “full review” by the Commission, the 90th calendar day following
the date such additional Registration Statement is required to be filed hereunder); provided, however, that in the
event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed or
is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth
(5th) Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise
required above; provided, further, that if such Effectiveness Date falls on a day that is not a Trading Day, then
the Effectiveness Date shall be the next succeeding Trading Day.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

“Filing
Date” means, with respect to the Initial Registration Statement required hereunder, the 30th calendar day
following the Closing Date and, with respect to any additional Registration Statements which may be required pursuant to Section
2(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement
related to the Registrable Securities.

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

    	 

     

    

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“Plan
of Distribution” shall have the meaning set forth in Section 2(a).

 

“Proceeding(s)”
means any writ, injunction, decree, order, judgment, lawsuit, claim, action, arbitration, proceeding, investigation, summons,
audit or hearing (in each case, whether civil, criminal, administrative, investigative or informal) commenced, brought, conducted
or heard by or before, or otherwise involving, any governmental authority.

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments
and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to
be incorporated by reference in such Prospectus.

 

“Registrable
Securities” means, as of any date of determination, (a) all shares of Common Stock issued pursuant to the Purchase Agreement,
and (b) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar
event with respect to such securities; provided, however, that the Holder has completed and delivered to the Company a
Selling Stockholder Questionnaire and that any such Registrable Securities shall cease to be Registrable Securities (and the Company
shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto)
for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the
Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such
effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c)
such securities become eligible for resale without volume or manner-of-sale restrictions pursuant to Rule 144 (assuming that such
securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities
were issued or are issuable, were at no time held by any Affiliate of the Company), as reasonably determined by the Company, upon
the advice of counsel to the Company.

 

    	2

     

    

 

“Registration
Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional
registration statements contemplated by Section 2(c), including (in each case) the Prospectus, amendments and supplements to any
such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in any such registration statement.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Selling
Stockholder Questionnaire” means a questionnaire in the form attached as Annex B hereto, or such other form of
questionnaire as may reasonably be adopted by the Company from time to time.

 

“SEC
Guidance” means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.

 

2.
Resale Registration.

 

(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the
resale of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering
to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 (or Form
S-3, if available to register for resale the Registrable Securities, or such other form available to register for resale the Registrable
Securities) and shall contain substantially the “Plan of Distribution” attached hereto as Annex A. Subject
to the terms of this Agreement, the Company shall use its commercially reasonable efforts to cause a Registration Statement filed
under this Agreement to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in
any event no later than the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration
Statement continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement
(i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant
to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under
Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable
to the Transfer Agent and the affected Holders (the “Effectiveness Period”). The Company shall promptly notify
the Holders of the effectiveness of a Registration Statement. The Company shall file a final Prospectus with the Commission as
required by Rule 424.

 

    	3

     

    

 

(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the
Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on
a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable
efforts to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of
Registrable Securities permitted to be registered by the Commission, on Form S-1 or such other form available to register for
resale the Registrable Securities as a secondary offering, subject to the provisions of Section 2(e).

 

(c)
Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number
of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used commercially reasonable efforts to advocate with the Commission for the registration of all or a greater
portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number
of Registrable Securities to be registered on such Registration Statement will be reduced first to reduce or eliminate any securities
to be included by any Person other than a Holder. In the event of a cutback hereunder, the Company shall give the Holder at least
two (2) Trading Days prior written notice along with the calculations as to such Holder’s allotment. In the event the Company
amends the Initial Registration Statement in accordance with the foregoing, the Company will use its commercially reasonable efforts
to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of
securities in general, one or more registration statements on Form S-1 or such other form available to register for resale those
Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.

 

(d)
Each Holder agrees to furnish to the Company a completed Selling Stockholder Questionnaire within ten (10) Business Days following
the date of this Agreement. Each Holder further agrees that it shall not be entitled to be named as a selling security holder
in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time, unless such
Holder has returned to the Company a completed and signed Selling Stockholder Questionnaire. If a Holder of Registrable Securities
returns a Selling Stockholder Questionnaire after the deadline specified in this Section 2(d), the Company shall use its commercially
reasonable efforts to take such actions as are required to name such Holder as a selling security holder in the Registration Statement
or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration
Statement the Registrable Securities identified in such late Selling Stockholder Questionnaire; provided that the Company shall
not be required to file an additional Registration Statement solely for such shares. Each Holder acknowledges and agrees that
the information in the Selling Stockholder Questionnaire will be used and relied upon by the Company in the preparation of the
Registration Statement and hereby consents to the inclusion of such information in the Registration Statement.

 

    	4

     

    

 

3.
Registration Procedures.

 

In
connection with the Company’s registration obligations hereunder, the Company shall:

 

(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto, the Company shall (i) furnish to each Holder copies
of all such documents proposed to be filed, which documents will be subject to the reasonable review of such Holders, and (ii)
use its commercially reasonable efforts to cause its officers and directors, counsel and independent registered public accountants
to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct
a reasonable investigation within the meaning of the Securities Act. Notwithstanding the above, the Company shall not be obligated
to provide the Holders advance copies of any universal shelf registration statement registering securities in addition to those
required hereunder, or any Prospectus prepared thereto.

 

(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to
the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related
Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and,
as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably practicable to any comments
received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably
practicable to the Holders true and complete copies of all correspondence from and to the Commission related to and/or applicable
to a Holder in the reasonable opinion of the Company relating to a Registration Statement (provided that, the Company shall excise
any information contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries),
and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect
to the disposition of all Registrable Securities covered by a Registration Statement during the Effectiveness Period in accordance
(subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration
Statement as so amended or in such Prospectus as so supplemented.

 

    	5

     

    

 

(c)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be
accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as
reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested
by any such Person) confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus
or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission
notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission comments
in writing on such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when
the same has become effective, (ii) of any request by the Commission or any other federal or state governmental authority for
amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii) of the issuance by the
Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration
Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose, (iv) of the
receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification
of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such
purpose, and (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration
Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be,
it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, provided,
however, in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries.

 

(d)
Use its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping
or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification)
of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.

 

(e)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such
Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to clauses (iii) through (vi)
of Section 3(c).

 

(f)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification)
of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within
the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom)
effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition
in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall
not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company
to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in
any such jurisdiction.

 

    	6

     

    

 

(g)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free,
to the extent permitted by the Purchase Agreement (solely with respect to Holders a party thereto) and applicable securities laws,
of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names
as any such Holder may reasonably request.

 

(h)
Upon the occurrence of any event contemplated by Section 3(c), as promptly as reasonably practicable under the circumstances taking
into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the
premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration
Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference,
and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will
contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies
the Holders in accordance with clauses (iii) through (vi) of Section 3(c) above to suspend the use of any Prospectus until the
requisite changes to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use
its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. In
addition, if (i) there is material non-public information regarding the Company which the Company’s Board of Directors (the
“Board”) determines not to be in the Company’s best interest to disclose and which the Company is not
otherwise required to disclose, or (ii) there is a significant business opportunity (including, but not limited to, the acquisition
or disposition of assets (other than in the ordinary course of business) or any merger, consolidation, tender offer or other similar
transaction) available to the Company which the Board determines not to be in the Company’s best interest to disclose, then
the Company may (x) postpone or suspend filing of a registration statement for a period not to exceed forty-five (45) consecutive
days or (y) postpone or suspend effectiveness of a registration statement for a period not to exceed forty-five (45) consecutive
days; provided, that the Company may not postpone or suspend effectiveness of a registration statement under this
Section for more than ninety (90) days in the aggregate during any three hundred sixty (360) day period; provided, however,
that no such postponement or suspension shall be permitted for consecutive twenty (20) day periods arising out of the same set
of facts, circumstances or transactions.

 

(i)
Comply in all material respects with all applicable rules and regulations of the Commission.

 

    	7

     

    

 

(j)
The Company shall require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common
Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares, pursuant to the Selling Stockholder Questionnaire.

 

4.
Registration Expenses. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees
and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including,
without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect
to filings made with the Commission, (B) with respect to filings required to be made with any trading market on which the Common
Stock is then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by
the Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue
Sky qualifications or exemptions of the Registrable Securities) and (D) if not previously paid by the Company in connection with
an issuer filing, with respect to any filing that may be required to be made by any broker through which a Holder intends to make
sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary
brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing
certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel
for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses
of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement.
In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of
the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and
employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection
with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company
be responsible for any broker or similar commissions of any Holder or, except to the extent of reasonable legal fees and disbursements
of one firm to represent the Purchasers, , any legal fees or other costs of the Holders.

 

    	8

     

    

 

5.
Indemnification.

 

(a)
Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable
Securities as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors
and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack
of such title or any other title) of each Holder, each Person who controls any such Holder (within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and
employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of
such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against
any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and
expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue
statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment
or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a
material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading or (2) any violation by the Company of the Securities
Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of
its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions
are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein,
or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this
purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(vi), the use by such Holder
of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus
is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated
in Section 6(d), but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise
to such Loss would have been corrected. The Company shall notify the Holders promptly of the institution, threat or assertion
of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware.

 

(b)
Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its
directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities
Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the
fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely
upon: (x) such Holder’s failure to comply with any applicable prospectus delivery requirements of the Securities Act through
no fault of the Company or (y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement,
any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any
omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in
the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i)
to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in
writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the
extent, but only to the extent, that such information relates to such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it
being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or in any amendment or supplement
thereto or (iii) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(vi), to the extent, but
only to the extent, related to the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the
Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such
Holder and prior to the receipt by such Holder of the Advice contemplated in Section 6(d), but only if and to the extent that
following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. In no event
shall the liability of any selling Holder under this Section 5(b) be greater in amount than the dollar amount of the net proceeds
received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

    	9

     

    

 

(c)
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume
the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all
fees and expenses incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such
notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only)
to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to
appeal or further review) that such failure shall have materially and adversely prejudiced the Indemnifying Party.

 

An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying
Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the
defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or
(3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying
Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if
the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party
notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party,
the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more
than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any
settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed.
No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending
Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such
Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

 

    	10

     

    

 

(d)
Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient
to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable
by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified
Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable
considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among
other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission
or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party
or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include,
subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by
such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if
the indemnification provided for in this Section was available to such party in accordance with its terms.

 

The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by
pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to
contribute pursuant to this Section 5(d), in the aggregate, any amount in excess of the amount by which the net proceeds actually
received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages
that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission, except in the case of fraud by a Holder.

 

The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties
may have to the Indemnified Parties.

 

6.
Miscellaneous.

 

(a)
Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under
this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each
of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by
reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action
for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would
be adequate.

 

    	11

     

    

 

(b)
No Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Except as contemplated by the October
2020 RRA and as set forth in Section 6(e), neither the Company nor any of its security holders (other than the Holders in such
capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities.
The Company shall not file any other registration statements until a Registration Statement has been filed with the Commission
covering all of the Registrable Securities, provided that this Section 6(b) (i) shall not prohibit the Company from filing amendments
to registration statements filed prior to the date of this Agreement and (ii) shall not prohibit the Company from filing a shelf
registration statement on Form S-3 for a primary offering by the Company, provided that the Company makes no offering of securities
pursuant to such shelf registration statement prior to the effective date of the Registration Statement required hereunder that
includes all of the Registrable Securities; provided, however, that upon the filing of a Registration Statement covering all of
the Registrable Securities, the Company shall be permitted to file any other registration statements in connection with a primary
offering regardless of whether a Registration Statement covering all of the Registrable Securities has been declared effective
by the Commission; provided, further, that once all Registrable Securities are registered pursuant to a Registration Statement
that is declared effective by the Commission, the Company shall be permitted to file any other registration statements.

 

(c)
Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities
Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant
to a Registration Statement.

 

(d)
Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(c)(iii) through (vi), such Holder will forthwith
discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company
will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.

 

(e)
Piggy-Back Registrations. If, at any time during the Effectiveness Period, there is not an effective Registration Statement
covering all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration
statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities,
other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity
securities to be issued solely in connection with any acquisition of any entity or business or equity securities issuable in connection
with the Company’s stock option or other employee benefit plans, then the Company shall deliver to each Holder a written
notice of such determination and, if within ten (10) days after the date of the delivery of such notice, any such Holder shall
so request in writing, the Company shall include in such registration statement all or any part of such Registrable Securities
such Holder requests to be registered; provided, however, that the Company shall not be required to register any
Registrable Securities pursuant to this Section 6(e) that are eligible for resale pursuant to Rule 144 (without volume restrictions
or current public information requirements) promulgated by the Commission pursuant to the Securities Act or that are the subject
of a then effective Registration Statement.

 

    	12

     

    

 

(f)
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall
be in writing and signed by the Company and the Holders of at least a majority of the then outstanding Registrable Securities.
If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in compliance
with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata
among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from
such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect
the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of
any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.

 

(g)
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the Purchase Agreement.

 

(h)
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights
or obligations hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities.
Each Holder may assign their respective rights hereunder to any Person to whom such Purchaser assigns or transfers any Registrable
Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Registrable Securities,
by the provisions of this Agreement and any other Transaction Document that applies to the Purchasers.

 

(i)
No Inconsistent Agreements. Except in connection with that certain registration rights agreement dated as of October 14,
2020 (the “October 2020 RRA”), neither the Company nor any of its Subsidiaries has entered, as of the date
hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with
respect to its securities, that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise
conflicts in any material respect with the provisions hereof. Except for the October 2020 RRA, neither the Company nor any of
its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities
to any Person that have not been satisfied in full.

 

    	13

     

    

 

(j)
Execution and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any
signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

(k)
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the provisions of the Purchase Agreement.

 

(l)
Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

(m)
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

(n)
Headings. The headings in this Agreement are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof.

 

(o)
Independent Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not
joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of
the obligations of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any
closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership,
an association, a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way
acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement
or any other matters. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights
arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding
for such purpose. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.

 

********************

 

(Signature
Pages Follow)

 

    	14

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	TARONIS
    FUELS, INC.
	 	 	 
	 	By:	 
	 	Name:	Scott
    Mahoney
	 	Title:	Chief
    Executive Officer

 

[SIGNATURE
PAGE OF HOLDERS FOLLOWS]

 

    	 

     

    

 

[SIGNATURE
PAGE OF HOLDERS TO RRA]

 

Name
of Holder: __________________________

 

Signature
of Authorized Signatory of Holder: __________________________

 

Name
of Authorized Signatory: _________________________

 

Title
of Authorized Signatory: __________________________

 

[SIGNATURE
PAGES CONTINUE]

 

    	 

     

    

 

Annex
A

 

Plan
of Distribution

 

Each
Selling Stockholder (the “Selling Stockholders”) of the securities and any of their pledgees, assignees and
successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal trading market
or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales
may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

 

	 	●	ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;
	 	 	 
	 	●	block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the
    block as principal to facilitate the transaction;
	 	 	 
	 	●	purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;
	 	 	 
	 	●	an
    exchange distribution in accordance with the rules of the applicable exchange;
	 	 	 
	 	●	privately
    negotiated transactions;
	 	 	 
	 	●	settlement
    of short sales entered into after the effective date of the registration statement of which this prospectus is a part;
	 	 	 
	 	●	in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities
    at a stipulated price per security;
	 	 	 
	 	●	through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;
	 	 	 
	 	●	a
    combination of any such methods of sale; or
	 	 	 
	 	●	any
    other method permitted pursuant to applicable law.

 

The
Selling Stockholders may also sell securities under Rule 144 under the Securities Act of 1933, as amended (the “Securities
Act”), if available, rather than under this prospectus.

 

    	 

     

    

 

Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an
agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a
principal transaction a markup or markdown in compliance with FINRA IM-2440.

 

In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of
hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close
out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling
Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered
by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).

 

The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters”
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities.

 

The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The
Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities
under the Securities Act.

 

Because
Selling Stockholders may be deemed to be “underwriters” within the meaning of the Securities Act, they will be subject
to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered
by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than
under this prospectus. The Selling Stockholders have advised us that there is no underwriter or coordinating broker acting in
connection with the proposed sale of the resale securities by the Selling Stockholders.

 

We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without
the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act
or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under
the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.

 

Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable
provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of
purchases and sales of securities of the common stock by the Selling Stockholders or any other person. We will make copies of
this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus
to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

 

    	2

     

    

 

Annex
B

 

TARONIS
FUELS, INC.

 

Selling
Stockholder Notice and Questionnaire

 

The
undersigned beneficial owner of common stock (the “Registrable Securities”) of TARONIS FUELS, INC., a Delaware
corporation (the “Company”), understands that the Company has filed or intends to file with the Securities
and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”)
for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”),
of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights
Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company
upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed
thereto in the Registration Rights Agreement.

 

In
order to sell or otherwise dispose of any Registrable Securities pursuant to the Registration Statement, a holder of Registrable
Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as
so supplemented, the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including
pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Registration Rights Agreement (including
certain indemnification provisions, as described below). Holders must complete and deliver this Notice and Questionnaire in order
to be named as selling stockholders in the Prospectus. Holders of Registrable Securities who do not complete, execute and return
this Notice and Questionnaire within ten (10) Business Days following the date of the Agreement (1) will not be named as selling
stockholders in the Resale Registration Statement or the Prospectus and (2) may not use the Prospectus for resales of Registrable
Securities.

 

Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the
consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.

 

NOTICE

 

The
undersigned beneficial owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include
the Registrable Securities owned by it in the Registration Statement.

 

    	3

     

    

 

The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

1.
Name.

 

	 	(a)	Full
    Legal Name of Selling Stockholder
	 	 	 
	 	 	 
	 	(b)	Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:
	 	 	 
	 	 	 
	 	(c)	Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power
    to vote or dispose of the securities covered by this Questionnaire):
	 	 	 

 

2.
Address for Notices to Selling Stockholder:

 

	 
	 
	 
	 	Telephone:

                                                                                 

	 	Fax:

                                                                                 

	 	Contact

                                                                                Person:

                                                                                 

 

    	4

     

    

 

3.
Broker-Dealer Status:

 

	 	(a)
    	Are
    you a broker-dealer?
	 	 	 
	Yes
    [  ]          No [  ]
	 	 	 
	 	(b)	If
    “yes” to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services
    to the Company?
	 	 	 
	Yes
    [  ]          No [  ]
	 	 	 
	 	Note:	If
    “no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter
    in the Registration Statement.
	 	 	 
		(c)
    	Are
    you an affiliate of a broker-dealer?
	 	 	 
	Yes
    [  ]          No [  ]
	 	 	 
	 	 (d)
    	If
    you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course
    of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings,
    directly or indirectly, with any person to distribute the Registrable Securities?
	 	 	 
	Yes
    [  ]          No [  ]
	 	 	 
	 	Note:
    	If
    “no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter
    in the Registration Statement.

 

4.
Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.

 

	 	Except
    as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company
    other than the securities issuable pursuant to the Purchase Agreement.
	 	 	 
	 	(a)
    	Type
    and Amount of other securities beneficially owned by the Selling Stockholder:
	 	 	 
	 	 	 
	 	 	 
	 	(b)
    	Number
    of shares of Common Stock to be registered pursuant to this Notice for resale:
	 	 	 
	 	 	 

 

5.
Relationships with the Company:

 

	 	Except
    as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners
    of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship
    with the Company (or its predecessors or affiliates) during the past three years.
	 	 
	 	State
    any exceptions here:
	 	 
	 	 

 

    	5

     

    

 

The
undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur
subsequent to the date hereof at any time while the Registration Statement remains effective.

 

By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through
5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements
thereto. The undersigned understands that such information will be relied upon by the Company in connection with the preparation
or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.

 

IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered
either in person or by its duly authorized agent.

 

	Date:
    	 	 	Beneficial
    Owner: 	

 

	 	By:	 
	 	Name:	 
	 	Title:	 

 

    	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]